{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ABC transporters", "ABCG1", "Alzheimer's disease", "Cholesterol", "beta secretase"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38275217", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1111/bcpt.13981"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "26"}], "Journal": {"ISSN": "1742-7843", "JournalIssue": {"Volume": "134", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Apr"}}, "Title": "Basic & clinical pharmacology & toxicology", "ISOAbbreviation": "Basic Clin Pharmacol Toxicol"}, "ArticleTitle": "The role of ATP-binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms.", "Pagination": {"StartPage": "423", "EndPage": "438", "MedlinePgn": "423-438"}, "Abstract": {"AbstractText": ["The maintenance of cholesterol homeostasis is essential for central nervous system function. Consequently, factors that affect cholesterol homeostasis are linked to neurological disorders and pathologies. Among them, ATP-binding cassette transporter G1 (ABCG1) plays a significant role in atherosclerosis. However, its role in Alzheimer's disease (AD) is unclear. There is inconsistent information regarding ABCG1's role in AD. It can increase or decrease amyloid \u03b2 (A\u03b2) levels in animals' brains. Clinical studies show that ABCG1 is involved in AD patients' impairment of cholesterol efflux capacity (CEC) in the cerebrospinal fluid (CSF). Lower A\u03b2 levels in the CSF are correlated with ABCG1-mediated CEC dysfunction. ABCG1 modulates \u03b1-, \u03b2-, and \u03b3-secretase activities in the plasma membrane and may affect A\u03b2 production in the mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) cell compartment. Despite contradictory findings regarding ABCG1's role in AD, this review shows that ABCG1 has a role in A\u03b2 generation via modulation of membrane secretases. It is, however, necessary to investigate the underlying mechanism(s). ABCG1 may also contribute to AD pathology through its role in apoptosis and oxidative stress. As a result, ABCG1 plays a role in AD and is a candidate for drug development."], "CopyrightInformation": "\u00a9 2024 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Yazdi", "ForeName": "Mohsen Karbasi", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Alavi", "ForeName": "Mohaddeseh Sadat", "Initials": "MS"}, {"Identifier": ["0000-0001-5032-4263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Roohbakhsh", "ForeName": "Ali", "Initials": "A"}], "GrantList": [{"Agency": "Mashhad University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Basic Clin Pharmacol Toxicol", "NlmUniqueID": "101208422", "ISSNLinking": "1742-7835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "ATP-Binding Cassette Transporters"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}, {"RegistryNumber": "0", "NameOfSubstance": "ABCG1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "ATP Binding Cassette Transporter, Subfamily G, Member 1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": ["metabolism"], "DescriptorName": "ATP-Binding Cassette Transporters"}, {"QualifierName": ["metabolism"], "DescriptorName": "Brain"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholesterol"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "ATP Binding Cassette Transporter, Subfamily G, Member 1"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "van der Kant R, Goldstein LSB, Ossenkoppele R. Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21(1):21-35. doi:10.1038/s41583-019-0240-3"}, {"Citation": "Soheili M, Karimian M, Hamidi G, Salami M. Alzheimer's disease treatment: the share of herbal medicines. Iran J Basic Med Sci. 2021;24(2):123-135. doi:10.22038/IJBMS.2020.50536.11512"}, {"Citation": "Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci U S A. 2021;118(33). doi:10.1073/pnas.2102191118"}, {"Citation": "Willem M, Tahirovic S, Busche MA, et al. \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature. 2015;526(7573):443-447. doi:10.1038/nature14864"}, {"Citation": "Checler F, Sunyach C, Pardossi-Piquard R, et al. The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. Curr Alzheimer Res. 2007;4(4):423-426. doi:10.2174/156720507781788945"}, {"Citation": "Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med. 2006;12(7):856-861. doi:10.1038/nm1438"}, {"Citation": "Jeremic D, Jim\u00e9nez-D\u00edaz L, Navarro-L\u00f3pez JD. Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer's disease: a systematic review. Ageing Res Rev. 2021;72:101496. doi:10.1016/j.arr.2021.101496"}, {"Citation": "Xiang Y, Bu X-L, Liu Y-H, et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease. Acta Neuropathol. 2015;130(4):487-499. doi:10.1007/s00401-015-1477-1"}, {"Citation": "Qosa H, Abuasal BS, Romero IA, et al. Differences in amyloid-\u03b2 clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling. Neuropharmacology. 2014;79:668-678. doi:10.1016/j.neuropharm.2014.01.023"}, {"Citation": "Yan R, Vassar R. Targeting the \u03b2 secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 2014;13(3):319-329. doi:10.1016/S1474-4422(13)70276-X"}, {"Citation": "Yang LB, Lindholm K, Yan R, et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med. 2003;9(1):3-4. doi:10.1038/nm0103-3"}, {"Citation": "Koudinov AR, Berezov TT, Koudinova NV. The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology? Neurosci Lett. 2001;314(3):115-118. doi:10.1016/S0304-3940(01)02263-7"}, {"Citation": "Sturchio A, Dwivedi AK, Malm T, et al. High soluble amyloid-\u03b242 predicts normal cognition in amyloid-positive individuals with Alzheimer's disease-causing mutations. J Alzheimers Dis. 2022;90(1):333-348. doi:10.3233/JAD-220808"}, {"Citation": "Piaceri I, Nacmias B, Sorbi S. Genetics of familial and sporadic Alzheimer's disease. Front Biosci (Elite Ed). 2013;5(1):167-177. doi:10.2741/E605"}, {"Citation": "Kim DH, Yeo SH, Park JM, et al. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Gene. 2014;545(2):185-193. doi:10.1016/j.gene.2014.05.031"}, {"Citation": "Bruni AC, Conidi ME, Bernardi L. Genetics in degenerative dementia: current status and applicability. Alzheimer Dis Assoc Disord. 2014;28(3):199-205. doi:10.1097/WAD.0000000000000046"}, {"Citation": "Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008;18(2):253-266. doi:10.1111/j.1750-3639.2008.00133.x"}, {"Citation": "Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science. 2010;330(6012):1774. doi:10.1126/science.1197623"}, {"Citation": "Dong HK, Gim JA, Yeo SH, Kim HS. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: cholesterol metabolism and trafficking perspectives. Gene. 2017;597:10-16. doi:10.1016/j.gene.2016.10.022"}, {"Citation": "Wray S, Noble W. Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity. J Neurosci. 2009;29(31):9665-9667. doi:10.1523/JNEUROSCI.2234-09.2009"}, {"Citation": "Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12(2):105-112. doi:10.1097/00041433-200104000-00003"}, {"Citation": "Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110(5):597-603. doi:10.1172/JCI0216390"}, {"Citation": "Egawa J, Pearn ML, Lemkuil BP, Patel PM, Head BP. Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function. J Physiol. 2016;594(16):4565-4579. doi:10.1113/JP270590"}, {"Citation": "Hussain G, Wang J, Rasul A, et al. Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis. 2019;18(1):26. doi:10.1186/s12944-019-0965-z"}, {"Citation": "Sun MY, Linsenbardt AJ, Emnett CM, et al. 24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival. Neuroscientist. 2016;22(2):132-144. doi:10.1177/1073858414568122"}, {"Citation": "Almeida RG, Lyons DA. On the resemblance of synapse formation and CNS myelination. Neuroscience. 2014;276:98-108. doi:10.1016/j.neuroscience.2013.08.062"}, {"Citation": "Almeida RG, Lyons DA. On myelinated axon plasticity and neuronal circuit formation and function. J Neurosci. 2017;37(42):10023-10034. doi:10.1523/JNEUROSCI.3185-16.2017"}, {"Citation": "Nieweg K, Schaller H, Pfrieger FW. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem. 2009;109(1):125-134. doi:10.1111/j.1471-4159.2009.05917.x"}, {"Citation": "Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6(4):254-264. doi:10.1007/s13238-014-0131-3"}, {"Citation": "Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Cholesterol Dysmetabolism in Alzheimer's disease: a starring role for astrocytes? Antioxidants (Basel). 2021;10(12):10. doi:10.3390/antiox10121890"}, {"Citation": "Raulin AC, Martens YA, Bu G. Lipoproteins in the central nervous system: from biology to pathobiology. Annu Rev Biochem. 2022;91(1):731-759. doi:10.1146/annurev-biochem-032620-104801"}, {"Citation": "Matsuo M, Campenot RB, Vance DE, Ueda K, Vance JE. Involvement of low-density lipoprotein receptor-related protein and ABCG1 in stimulation of axonal extension by apoE-containing lipoproteins. Biochim Biophys Acta. 2011;1811(1):31-38. doi:10.1016/j.bbalip.2010.10.004"}, {"Citation": "Youmans KL, Tai LM, Nwabuisi-Heath E, et al. APOE4-specific changes in A\u03b2 accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 2012;287(50):41774-41786. doi:10.1074/jbc.M112.407957"}, {"Citation": "Li Y, Macyczko JR, Liu CC, Bu G. ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer's disease. Neurobiol Aging. 2022;115:20-28. doi:10.1016/j.neurobiolaging.2022.03.011"}, {"Citation": "Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180-184. doi:10.1038/ng0694-180"}, {"Citation": "Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer disease? Mol Cell Biochem. 2009;326(1-2):121-129. doi:10.1007/s11010-008-0012-2"}, {"Citation": "Dietschy JM, Turley SD. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45(8):1375-1397. doi:10.1194/jlr.R400004-JLR200"}, {"Citation": "Spady DK, Dietschy JM. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res. 1983;24(3):303-315. doi:10.1016/S0022-2275(20)37999-2"}, {"Citation": "Gliozzi M, Musolino V, Bosco F, et al. Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues. Pharmacol Res. 2021;163:105215. doi:10.1016/j.phrs.2020.105215"}, {"Citation": "Alavi MS, Karimi G, Ghanimi HA, Roohbakhsh A. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: an updated review of mechanisms. Eur J Pharmacol. 2023;949:175726. doi:10.1016/j.ejphar.2023.175726"}, {"Citation": "L\u00fctjohann D, Breuer O, Ahlborg G, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93(18):9799-9804. doi:10.1073/pnas.93.18.9799"}, {"Citation": "Bj\u00f6rkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol Aspects Med. 2009;30(3):171-179. doi:10.1016/j.mam.2009.02.001"}, {"Citation": "Liu JP, Tang Y, Zhou S, Toh BH, McLean C, Li H. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci. 2010;43(1):33-42. doi:10.1016/j.mcn.2009.07.013"}, {"Citation": "Xu H, Zheng LX, Chen XS, et al. Brain-specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injury. Brain Pathol. 2023;33(3):e13126. doi:10.1111/bpa.13126"}, {"Citation": "Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2008;16(5):535-541. doi:10.1038/ejhg.2008.10"}, {"Citation": "Cho YY, Kwon OH, Park MK, Kim TW, Chung S. Elevated cellular cholesterol in familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of \u03b2-amyloid precursor protein. PLoS ONE. 2019;14(1):e0210535. doi:10.1371/journal.pone.0210535"}, {"Citation": "Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol. 2003;160(1):113-123. doi:10.1083/jcb.200207113"}, {"Citation": "Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport. 2002;13(4):455-459. doi:10.1097/00001756-200203250-00019"}, {"Citation": "Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A. 2001;98(10):5815-5820. doi:10.1073/pnas.081612998"}, {"Citation": "Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998;95(11):6460-6464. doi:10.1073/pnas.95.11.6460"}, {"Citation": "Eckert GP, Reik C, M\u00fcller WE. Simvastatin alters membrane cholesterol distribution and beta-amyloid levels in brains of female APP751SL mice. Pharmazie. 2013;68(7):590-594."}, {"Citation": "Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98(10):5856-5861. doi:10.1073/pnas.081620098"}, {"Citation": "Langness VF, van der Kant R, Das U, Wang L, Chaves RDS, Goldstein LSB. Cholesterol-lowering drugs reduce APP processing to A\u03b2 by inducing APP dimerization. Mol Biol Cell. 2021;32(3):247-259. doi:10.1091/mbc.E20-05-0345"}, {"Citation": "Turri M, Conti E, Pavanello C, et al. Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease. Alzheimers Res Ther. 2023;15(1):95. doi:10.1186/s13195-023-01241-6"}, {"Citation": "Cipollari E, Szapary HJ, Picataggi A, et al. Correlates and predictors of cerebrospinal fluid cholesterol efflux capacity from neural cells, a family of biomarkers for cholesterol epidemiology in Alzheimer's disease. J Alzheimers Dis. 2020;74(2):563-578. doi:10.3233/JAD-191246"}, {"Citation": "Marchi C, Adorni MP, Caffarra P, et al. ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease. J Lipid Res. 2019;60(8):1449-1456. doi:10.1194/jlr.P091033"}, {"Citation": "Lane-Donovan C, Wong WM, Durakoglugil MS, et al. Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice. J Neurosci. 2016;36(39):10141-10150. doi:10.1523/JNEUROSCI.1054-16.2016"}, {"Citation": "Oitzl MS, Mulder M, Lucassen PJ, Havekes LM, Grootendorst J, de Kloet ER. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 1997;752(1-2):189-196. doi:10.1016/S0006-8993(96)01448-5"}, {"Citation": "Shi Y, Yamada K, Liddelow SA, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523-527. doi:10.1038/nature24016"}, {"Citation": "Wahrle SE, Jiang H, Parsadanian M, et al. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem. 2005;280(52):43236-43242. doi:10.1074/jbc.M508780200"}, {"Citation": "Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312. doi:10.1101/cshperspect.a006312"}, {"Citation": "Do TM, Dodacki A, Alata W, et al. Age-dependent regulation of the blood-brain barrier influx/efflux equilibrium of amyloid-\u03b2 peptide in a mouse model of Alzheimer's disease (3xTg-AD). J Alzheimers Dis. 2016;49(2):287-300. doi:10.3233/JAD-150350"}, {"Citation": "Storck SE, Meister S, Nahrath J, et al. Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier. J Clin Invest. 2016;126(1):123-136. doi:10.1172/JCI81108"}, {"Citation": "Storck SE, Hartz AMS, Bernard J, et al. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM. Brain Behav Immun. 2018;73:21-33. doi:10.1016/j.bbi.2018.07.017"}, {"Citation": "Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem. 2006;281(18):12799-12808. doi:10.1074/jbc.M601019200"}, {"Citation": "Bj\u00f6rkhem I, Heverin M, Leoni V, Meaney S, Diczfalusy U. Oxysterols and Alzheimer's disease. Acta Neurol Scand Suppl. 2006;185(s185):43-49. doi:10.1111/j.1600-0404.2006.00684.x"}, {"Citation": "Vanmierlo T, Rutten K, Dederen J, et al. Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging. 2011;32(7):1262-1272. doi:10.1016/j.neurobiolaging.2009.07.005"}, {"Citation": "Paseban T, Alavi MS, Etemad L, Roohbakhsh A. The role of the ATP-binding cassette A1 (ABCA1) in neurological disorders: a mechanistic review. Expert Opin Ther Targets. 2023;1-22(7):531-552. doi:10.1080/14728222.2023.2235718"}, {"Citation": "Juan-Carlos PM, Perla-Lidia PP, Stephanie-Talia MM, M\u00f3nica-Griselda AM, Luz-Mar\u00eda TE. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine. Mol Biol Rep. 2021;48(2):1883-1901. doi:10.1007/s11033-021-06155-w"}, {"Citation": "Katzeff JS, Kim WS. ATP-binding cassette transporters and neurodegenerative diseases. Essays Biochem. 2021;65(7):1013-1024. doi:10.1042/EBC20210012"}, {"Citation": "ter Beek J, Guskov A, Slotboom DJ. Structural diversity of ABC transporters. J Gen Physiol. 2014;143(4):419-435. doi:10.1085/jgp.201411164"}, {"Citation": "Barthelme D, Dinkelaker S, Albers SV, Londei P, Ermler U, Tamp\u00e9 R. Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1. Proc Natl Acad Sci U S A. 2011;108(8):3228-3233. doi:10.1073/pnas.1015953108"}, {"Citation": "Bo\u00ebl G, Smith PC, Ning W, et al. The ABC-F protein EttA gates ribosome entry into the translation elongation cycle. Nat Struct Mol Biol. 2014;21(2):143-151. doi:10.1038/nsmb.2740"}, {"Citation": "Mahringer A, Fricker G. ABC transporters at the blood-brain barrier. Expert Opin Drug Metab Toxicol. 2016;12(5):499-508. doi:10.1517/17425255.2016.1168804"}, {"Citation": "Ho YS, Torres-Vergara P, Penny J. Regulation of the ATP-binding cassette transporters ABCB1, ABCG2 and ABCC5 by nuclear receptors in porcine blood-brain barrier endothelial cells. British J Pharmacol. 2023;180(23):3092-3109. doi:10.1111/bph.16196"}, {"Citation": "Kerr ID, Hutchison E, Gerard L, Aleidi SM, Gelissen IC. Mammalian ABCG-transporters, sterols and lipids: to bind perchance to transport? Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(3):158860. doi:10.1016/j.bbalip.2020.158860"}, {"Citation": "Cserepes J, Szentp\u00e9tery Z, Seres L, et al. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem Biophys Res Commun. 2004;320(3):860-867. doi:10.1016/j.bbrc.2004.06.037"}, {"Citation": "Hegyi Z, Homolya L. Functional cooperativity between ABCG4 and ABCG1 isoforms. PLoS ONE. 2016;11(5):e0156516. doi:10.1371/journal.pone.0156516"}, {"Citation": "Kober AC, Manavalan APC, Tam-Amersdorfer C, et al. Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(6):573-588. doi:10.1016/j.bbalip.2017.03.003"}, {"Citation": "Chen H, Rossier C, Lalioti MD, et al. Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3. Am J Hum Genet. 1996;59(1):66-75."}, {"Citation": "Savary S, Denizot F, Luciani M, Mattei M, Chimini G. Molecular cloning of a mammalian ABC transporter homologous to Drosophila white gene. Mamm Genome. 1996;7(9):673-676. doi:10.1007/s003359900203"}, {"Citation": "Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005;1(2):121-131. doi:10.1016/j.cmet.2005.01.002"}, {"Citation": "Bald\u00e1n A, Tarr P, Vales CS, et al. Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis. J Biol Chem. 2006;281(39):29401-29410. doi:10.1074/jbc.M606597200"}, {"Citation": "Matsuo M. ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis. J Pharmacol Sci. 2022;148(2):197-203. doi:10.1016/j.jphs.2021.11.005"}, {"Citation": "Singaraja RR, Fievet C, Castro G, et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest. 2002;110(1):35-42. doi:10.1172/JCI0215748"}, {"Citation": "M\u00fcnch G, B\u00fcltmann A, Li Z, et al. Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits. Heart Int. 2012;7(2):e12. doi:10.4081/hi.2012.e12"}, {"Citation": "Karten B, Campenot RB, Vance DE, Vance JE. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J Biol Chem. 2006;281(7):4049-4057. doi:10.1074/jbc.M508915200"}, {"Citation": "Sturek JM, Castle JD, Trace AP, et al. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J Clin Invest. 2010;120(7):2575-2589. doi:10.1172/JCI41280"}, {"Citation": "Zhao J, Fu Y, Liu CC, et al. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. J Biol Chem. 2014;289(16):11282-11292. doi:10.1074/jbc.M113.526095"}, {"Citation": "Riddell DR, Zhou H, Comery TA, et al. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol Cell Neurosci. 2007;34(4):621-628. doi:10.1016/j.mcn.2007.01.011"}, {"Citation": "Yvan-Charvet L, Welch C, Pagler TA, et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation. 2008;118(18):1837-1847. doi:10.1161/CIRCULATIONAHA.108.793869"}, {"Citation": "Engel T, Fobker M, Buchmann J, et al. 3\u03b2,5\u03b1,6\u03b2-Cholestanetriol and 25-hydroxycholesterol accumulate in ATP-binding cassette transporter G1 (ABCG1)-deficiency. Atherosclerosis. 2014;235(1):122-129. doi:10.1016/j.atherosclerosis.2014.04.023"}, {"Citation": "Luu W, Sharpe LJ, Capell-Hattam I, Gelissen IC, Brown AJ. Oxysterols: old tale, new twists. Annu Rev Pharmacol Toxicol. 2016;56(1):447-467. doi:10.1146/annurev-pharmtox-010715-103233"}, {"Citation": "Bojanic DD, Tarr PT, Gale GD, et al. Differential expression and function of ABCG1 and ABCG4 during development and aging. J Lipid Res. 2010;51(1):169-181. doi:10.1194/jlr.M900250-JLR200"}, {"Citation": "Prasanthi JR, Huls A, Thomasson S, Thompson A, Schommer E, Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener. 2009;4(1):1. doi:10.1186/1750-1326-4-1"}, {"Citation": "Okabe A, Urano Y, Itoh S, et al. Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death. Redox Biol. 2013;2:28-35. doi:10.1016/j.redox.2013.11.007"}, {"Citation": "Wu Y, Chen L, Xie Z, Wang C, Zhang J, Yan X. Effects of ABCG1 knockout on proteomic composition of HDL in mice on a chow diet and a high-fat diet. Proteomics. 2022;22(10):e2100028. doi:10.1002/pmic.202100028"}, {"Citation": "Kobayashi A, Takanezawa Y, Hirata T, et al. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res. 2006;47(8):1791-1802. doi:10.1194/jlr.M500546-JLR200"}, {"Citation": "Chen L, Zhao ZW, Zeng PH, Zhou YJ, Yin WJ. Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle. 2022;21(11):1121-1139. doi:10.1080/15384101.2022.2042777"}, {"Citation": "Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest. 2007;117(12):3900-3908. doi:10.1172/JCI33372"}, {"Citation": "Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A. 2004;101(26):9774-9779. doi:10.1073/pnas.0403506101"}, {"Citation": "Casta\u00f1o D, Rattanasopa C, Monteiro-Cardoso VF, et al. Lipid efflux mechanisms, relation to disease and potential therapeutic aspects. Adv Drug Deliv Rev. 2020;159:54-93. doi:10.1016/j.addr.2020.04.013"}, {"Citation": "Tarling EJ, Edwards PA. ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter. Proc Natl Acad Sci U S A. 2011;108(49):19719-19724. doi:10.1073/pnas.1113021108"}, {"Citation": "Li G, Gu HM, Zhang DW. ATP-binding cassette transporters and cholesterol translocation. IUBMB Life. 2013;65(6):505-512. doi:10.1002/iub.1165"}, {"Citation": "Kim WS, Rahmanto AS, Kamili A, et al. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem. 2007;282(5):2851-2861. doi:10.1074/jbc.M607831200"}, {"Citation": "Werkman IL, K\u00f6vilein J, de Jonge JC, Baron W. Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination. J Neurochem. 2021;156(5):624-641. doi:10.1111/jnc.15113"}, {"Citation": "Tarr PT, Edwards PA. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J Lipid Res. 2008;49(1):169-182. doi:10.1194/jlr.M700364-JLR200"}, {"Citation": "Gelissen IC, Sharpe LJ, Sandoval C, et al. Protein kinase A modulates the activity of a major human isoform of ABCG1. J Lipid Res. 2012;53(10):2133-2140. doi:10.1194/jlr.M028795"}, {"Citation": "Nagelin MH, Srinivasan S, Nadler JL, Hedrick CC. Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways. J Biol Chem. 2009;284(45):31303-31314. doi:10.1074/jbc.M109.028910"}, {"Citation": "Watanabe T, Kioka N, Ueda K, Matsuo M. Phosphorylation by protein kinase C stabilizes ABCG1 and increases cholesterol efflux. J Biochem. 2019;166(4):309-315. doi:10.1093/jb/mvz039"}, {"Citation": "Sano O, Tsujita M, Shimizu Y, et al. ABCG1 and ABCG4 suppress \u03b3-secretase activity and amyloid \u03b2 production. PLoS ONE. 2016;11(5):e0155400. doi:10.1371/journal.pone.0155400"}, {"Citation": "Tansley GH, Burgess BL, Bryan MT, et al. The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein. J Lipid Res. 2007;48(5):1022-1034. doi:10.1194/jlr.M600542-JLR200"}, {"Citation": "Burgess BL, Parkinson PF, Racke MM, et al. ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo. J Lipid Res. 2008;49(6):1254-1267. doi:10.1194/jlr.M700481-JLR200"}, {"Citation": "Dafnis I, Raftopoulou C, Mountaki C, Megalou E, Zannis VI, Chroni A. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and A\u03b2 production independently of their cholesterol efflux capacity. Biochem J. 2018;475(10):1839-1859. doi:10.1042/BCJ20180068"}, {"Citation": "Sarnowski C, Hivert M-F, Liu C, et al. Epigenetic signatures of insulin resistance associated with Alzheimer's disease and related traits. Alzheimers Dement. 2022;18(S4):e059136. doi:10.1002/alz.059136"}, {"Citation": "Schon EA, Area-Gomez E. Mitochondria-associated ER membranes in Alzheimer disease. Mol Cell Neurosci. 2013;55:26-36. doi:10.1016/j.mcn.2012.07.011"}, {"Citation": "Schreiner B, Hedskog L, Wiehager B, Ankarcrona M. Amyloid-\u03b2 peptides are generated in mitochondria-associated endoplasmic reticulum membranes. J Alzheimers Dis. 2015;43(2):369-374. doi:10.3233/JAD-132543"}, {"Citation": "V\u00f6lgyi K, Badics K, Sialana FJ, et al. Early presymptomatic changes in the proteome of mitochondria-associated membrane in the APP/PS1 mouse model of Alzheimer's disease. Mol Neurobiol. 2018;55(10):7839-7857. doi:10.1007/s12035-018-0955-6"}, {"Citation": "Huo C, Chen MH, Hour TC, et al. Application of Micro-Western Array for identifying different serum protein expression profile among healthy control, Alzheimer's disease patients and patients' adult children. Brain Sci. 2022;12(9):12. doi:10.3390/brainsci12091134"}, {"Citation": "Davies G, Armstrong N, Bis JC, et al. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Mol Psychiatry. 2015;20(2):183-192. doi:10.1038/mp.2014.188"}, {"Citation": "Beecham GW, Hamilton K, Naj AC, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014;10(9):e1004606. doi:10.1371/journal.pgen.1004606"}, {"Citation": "Wollmer MA, Sleegers K, Ingelsson M, et al. Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 2007;8(3):179-188. doi:10.1007/s10048-007-0087-z"}, {"Citation": "Tsun JG, Shiu SW, Wong Y, Yung S, Chan TM, Tan KC. Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus. Atherosclerosis. 2013;231(2):405-410. doi:10.1016/j.atherosclerosis.2013.10.008"}, {"Citation": "Karki R, Madan S, Gadiya Y, Domingo-Fern\u00e1ndez D, Kodamullil AT, Hofmann-Apitius M. Data-driven modeling of knowledge assemblies in understanding comorbidity between type 2 diabetes mellitus and Alzheimer's disease. J Alzheimers Dis. 2020;78(1):87-95. doi:10.3233/JAD-200752"}, {"Citation": "Lee J, Park S, Kim Y, Kim HM, Oh CM. Exploring the genetic associations between the use of statins and Alzheimer's disease. J Lipid Atheroscler. 2022;11(2):133-146. doi:10.12997/jla.2022.11.2.133"}, {"Citation": "Parkinson PF, Kannangara TS, Eadie BD, Burgess BL, Wellington CL, Christie BR. Cognition, learning behaviour and hippocampal synaptic plasticity are not disrupted in mice over-expressing the cholesterol transporter ABCG1. Lipids Health Dis. 2009;8(1):5. doi:10.1186/1476-511X-8-5"}, {"Citation": "Alrosan A, Aleidi SM, Yang A, Brown AJ, Gelissen IC. The adaptor protein Alix is involved in the interaction between the ubiquitin ligase NEDD4-1 and its targets, ABCG1 and ABCG4. Int J Mol Sci. 2019;20(11):2714. doi:10.3390/ijms20112714"}, {"Citation": "Salehi A, Ashford JW, Mufson EJ. The link between Alzheimer's disease and Down syndrome. A historical perspective. Curr Alzheimer Res. 2016;13(1):2-6. doi:10.2174/1567205012999151021102914"}, {"Citation": "Erickson MA, Banks WA. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab. 2013;33(10):1500-1513. doi:10.1038/jcbfm.2013.135"}, {"Citation": "Ghribi O, Larsen B, Schrag M, Herman MM. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol. 2006;200(2):460-467. doi:10.1016/j.expneurol.2006.03.019"}, {"Citation": "Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer's disease. Int J Mol Sci. 2020;21(4):1505. doi:10.3390/ijms21041505"}, {"Citation": "Marquer C, Laine J, Dauphinot L, et al. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener. 2014;9(1):60. doi:10.1186/1750-1326-9-60"}, {"Citation": "Wen W, Li P, Liu P, Xu S, Wang F, Huang JH. Post-translational modifications of BACE1 in Alzheimer's disease. Curr Neuropharmacol. 2022;20(1):211-222. doi:10.2174/1570159X19666210121163224"}, {"Citation": "Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280(52):43224-43235. doi:10.1074/jbc.M504513200"}, {"Citation": "Houser MCQ, Mitchell SPC, Sinha P, Lundin B, Berezovska O, Maesako M. Endosome and lysosome membrane properties functionally link to \u03b3-secretase in live/intact cells. Sensors (Basel). 2023;23."}, {"Citation": "Hur JY. \u03b3-Secretase in Alzheimer's disease. Exp Mol Med. 2022;54(4):433-446. doi:10.1038/s12276-022-00754-8"}, {"Citation": "Pasternak SH, Bagshaw RD, Guiral M, et al. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem. 2003;278(29):26687-26694. doi:10.1074/jbc.M304009200"}, {"Citation": "Burlot MA, Braudeau J, Michaelsen-Preusse K, et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Hum Mol Genet. 2015;24(21):5965-5976. doi:10.1093/hmg/ddv268"}, {"Citation": "Sun Y, Fan J, Zhu Z, et al. Small molecule TBTC as a new selective retinoid X receptor \u03b1 agonist improves behavioral deficit in Alzheimer's disease model mice. Eur J Pharmacol. 2015;762:202-213. doi:10.1016/j.ejphar.2015.05.050"}, {"Citation": "Cao X, Zhang L, Chen C, et al. The critical role of ABCG1 and PPAR\u03b3/LXR\u03b1 signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells. Cell Tissue Res. 2017;368(1):145-157. doi:10.1007/s00441-016-2518-3"}, {"Citation": "Kruit JK, Wijesekara N, Westwell-Roper C, et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired \u03b2-cell function. Diabetes. 2012;61(3):659-664. doi:10.2337/db11-1341"}, {"Citation": "Soliman E, Bhalla S, Elhassanny AEM, et al. Myeloid ABCG1 deficiency enhances apoptosis and initiates efferocytosis in bronchoalveolar lavage cells of murine multi-walled carbon nanotube-induced granuloma model. Int J Mol Sci. 2021;23(1):47. doi:10.3390/ijms23010047"}, {"Citation": "Engel T, Kannenberg F, Fobker M, et al. Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol. FEBS Lett. 2007;581(8):1673-1680. doi:10.1016/j.febslet.2007.03.038"}, {"Citation": "Seres L, Cserepes J, Elkind NB, et al. Functional ABCG1 expression induces apoptosis in macrophages and other cell types. Biochim Biophys Acta. 2008;1778(10):2378-2387. doi:10.1016/j.bbamem.2008.06.010"}, {"Citation": "Erekat NS. Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat. 2022;35(1):65-78. doi:10.1002/ca.23792"}, {"Citation": "Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics. Inflammation. 2023;46(1):1-17. doi:10.1007/s10753-022-01721-1"}, {"Citation": "Roohbakhsh A, Etemad L, Karimi G. Resolvin D1: a key endogenous inhibitor of neuroinflammation. Biofactors. 2022;48(5):1005-1026. doi:10.1002/biof.1891"}, {"Citation": "Huang Q, Zhang C, Qu S, et al. Chinese herbal extracts exert neuroprotective effect in Alzheimer's disease mouse through the dopaminergic synapse/apoptosis signaling pathway. Front Pharmacol. 2022;13:817213. doi:10.3389/fphar.2022.817213"}, {"Citation": "Jiang H, Liu J, Guo S, et al. miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3\u03b2 signaling pathways. Mol Ther Nucleic Acids. 2022;28:539-557. doi:10.1016/j.omtn.2022.04.008"}, {"Citation": "Koudinov AR, Koudinova NV. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci. 2005;229-230:233-240. doi:10.1016/j.jns.2004.11.036"}, {"Citation": "Karpouzas GA, Papotti B, Ormseth SR, et al. ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis. J Autoimmun. 2023;136:103029. doi:10.1016/j.jaut.2023.103029"}, {"Citation": "O'Callaghan YC, Woods JA, O'Brien NM. Characteristics of 7 beta-hydroxycholesterol-induced cell death in a human monocytic blood cell line, U937, and a human hepatoma cell line, HepG2. Toxicol in Vitro. 2002;16(3):245-251. doi:10.1016/S0278-6915(02)00050-9"}, {"Citation": "Roussi S, Goss\u00e9 F, Aoud\u00e9-Werner D, et al. Mitochondrial perturbation, oxidative stress and lysosomal destabilization are involved in 7beta-hydroxysitosterol and 7beta-hydroxycholesterol triggered apoptosis in human colon cancer cells. Apoptosis. 2007;12(1):87-96. doi:10.1007/s10495-006-0485-y"}, {"Citation": "Navia-Pelaez JM, Choi SH, Dos Santosag Gumca Pettini L, et al. Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain. J Exp Med. 2021;218(7):218. doi:10.1084/jem.20202059"}, {"Citation": "Li Q, Liu X, Zhu R, He Z. Association of ATP-binding cassette transporter G1 polymorphisms with risk of ischemic stroke in the Chinese Han population. J Stroke Cerebrovasc Dis. 2015;24(6):1397-1404. doi:10.1016/j.jstrokecerebrovasdis.2015.02.024"}, {"Citation": "Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21(8):601-620. doi:10.1038/s41573-022-00470-y"}, {"Citation": "Tajbakhsh A, Read M, Barreto GE, \u00c1vila-Rodriguez M, Gheibi-Hayat SM, Sahebkar A. Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: pathological mechanisms and therapeutic outlooks. Eur J Pharmacol. 2021;895:173873. doi:10.1016/j.ejphar.2021.173873"}, {"Citation": "Yvan-Charvet L, Pagler TA, Seimon TA, et al. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ Res. 2010;106(12):1861-1869. doi:10.1161/CIRCRESAHA.110.217281"}, {"Citation": "Xue J, Fan J, Li Y, Wu W, Yan Q, Zheng Q. ABCG1 attenuates oxidative stress induced by H(2)O(2) through the inhibition of NADPH oxidase and the upregulation of Nrf2-mediated antioxidant defense in endothelial cells. Anal Cell Pathol (Amst). 2020;2020:2095645. doi:10.1155/2020/2095645"}, {"Citation": "Kumar S, Birge RB. Efferocytosis. Curr Biol. 2016;26(13):R558-r9. doi:10.1016/j.cub.2016.01.059"}, {"Citation": "Roberts KF, Elbert DL, Kasten TP, et al. Amyloid-\u03b2 efflux from the central nervous system into the plasma. Ann Neurol. 2014;76(6):837-844. doi:10.1002/ana.24270"}, {"Citation": "Deane R, Du Yan S, Submamaryan RK, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9(7):907-913. doi:10.1038/nm890"}, {"Citation": "Schulz JA, Hartz AMS, Bauer B. ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery. Pharmacol Rev. 2023;75(5):815-853. doi:10.1124/pharmrev.120.000025"}, {"Citation": "Wiseman FK, Al-Janabi T, Hardy J, et al. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci. 2015;16(9):564-574. doi:10.1038/nrn3983"}, {"Citation": "Kawarabayashi T, Shoji M, Younkin LH, et al. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2004;24(15):3801-3809. doi:10.1523/JNEUROSCI.5543-03.2004"}, {"Citation": "Sawamura N, Gong JS, Chang TY, Yanagisawa K, Michikawa M. Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells. J Neurochem. 2003;84(5):1086-1096. doi:10.1046/j.1471-4159.2003.01596.x"}, {"Citation": "Wheeler S, Sillence DJ. Niemann-Pick type C disease: cellular pathology and pharmacotherapy. J Neurochem. 2020;153(6):674-692. doi:10.1111/jnc.14895"}, {"Citation": "Wang MD, Franklin V, Sundaram M, et al. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J Biol Chem. 2007;282(31):22525-22533. doi:10.1074/jbc.M700326200"}, {"Citation": "Noveir SD, Kerman BE, Xian H, et al. Effect of the ABCA1 agonist CS-6253 on amyloid-\u03b2 and lipoprotein metabolism in cynomolgus monkeys. Alzheimers Res Ther. 2022;14(1):87. doi:10.1186/s13195-022-01028-1"}], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "1", "Day": "4"}, {"Year": "2023", "Month": "8", "Day": "8"}, {"Year": "2024", "Month": "1", "Day": "8"}, {"Year": "2024", "Month": "3", "Day": "15", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "26", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "26", "Hour": "7", "Minute": "48"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38275217", "10.1111/bcpt.13981"]}}]}